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Background: Protein aggregation during monoclonal antibody (mAb) production can occur in upstream and
downstream processing (DSP). Current methods to determine aggregate formation during cell culture include size
exclusion chromatography (SEC) with a previous affinity chromatography step in order to remove disturbing cell
culture components. The pre-purification step itself can already influence protein aggregation and therefore does
not necessarily reflect the real aggregate content present in cell culture. To analyze mAb aggregate formation
directly in the supernatant of Chinese hamster ovary (CHO) cell culture, we established a protocol, which allows
aggregate quantification using SEC, without a falsifying pre-purification step.
Results: The use of a 3 μm silica SEC column or a SEC column tailored for mAb aggregate analysis allows the separation
of mAb monomer and aggregates from disturbing cell culture components, which enables aggregate determination
directly in the supernatant. Antibody aggregate analysis of a mAb-producing CHO DG44 cell line demonstrated
the feasibility of the method. Astonishingly, the supernatant of the CHO cells consisted of over 75% mAb dimer
and larger oligomers, representing a substantially higher aggregate content than reported in literature so far.
Conclusion: This study highlights that aggregate quantification directly in the cell culture supernatant using
appropriate SEC columns with suitable mAb aggregate standards is feasible without falsification by previous
affinity chromatography. Moreover, our results indicate that aggregate formation should be addressed directly in
the cell culture and is not only a problem in DSP.
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Over the past ten years, the demand for monoclonal anti-
bodies (mAbs) as biopharmaceutical drugs for the treat-
ment of cancer and other diseases has increased [1-3].
Like other recombinant therapeutic proteins, mAbs are
mainly produced in mammalian cells, usually in Chinese
hamster ovary (CHO) cells [4]. Antibody manufacturing
includes several steps, where environmental factors such
as pH, temperature, ionic strength, protein concentration,
oxygen and shear forces can lead to aggregate formation
during upstream (USP) and downstream (DSP) processing
[5,6]. Kramarcyk et al. reported up to 20-30% aggregate
content of a partially purified mAb produced in CHO cells
[7]. Self-association and formation of aggregates are a
major concern for therapeutic applications, since aggre-
gates influence drug performance and safety [8,9].* Correspondence: paul@hochschule-bc.de
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unless otherwise stated.DSP offers the opportunity to remove aggregates, but
this often leads to a reduction of protein yields. Another
strategy involves reducing the formation of aggregates in
the cell culture [10]. Jing and colleagues showed that
proper control of culture conditions during USP suc-
cessfully reduced the level of protein aggregation and
improved the process yield [11]. To evaluate aggregate
formation upstream, suitable analytical methods for ag-
gregate detection and quantification are essential. This is
challenging, since the size of aggregates may range from
small oligomers to visible particles. Furthermore, host
cell proteins (HCPs) and cell culture medium compo-
nents may complicate aggregate detection. Nowadays,
investigation of protein aggregation during cell cultiva-
tion is usually performed after a Protein A capture step
[11-14]. Protein A affinity chromatography is a powerful
tool for antibody purification, but it also exposes anti-
bodies to pH-shifts [15]. This pH shift favors the forma-
tion of aggregates, since the aggregation rate of proteins. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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showed that acidic pH values of Protein A elution led to
substantial protein aggregation and precipitation [18].
This implies that Protein A purification itself might
influence the aggregation status, thus purified samples
do not necessarily reflect the aggregation state of mAbs
in cell culture.
Size exclusion chromatography (SEC) used in a high
pressure liquid chromatography (HPLC) system is the
most commonly applied analytical method for the ana-
lysis of soluble protein aggregates [19]. Typically, SEC
analysis is performed after Protein A chromatography-
based isolation of the mAbs from the cell culture super-
natant, because cell culture components interfere with
the direct analysis of mAb cell culture samples on SEC
columns [10]. In the present study, we developed a
procedure to analyze aggregate formation directly in the
supernatant of CHO cells without a pre-purification
step. Using a SEC column consisting of 3 μm silica parti-
cles or a SEC column especially tailored for mAb ana-
lysis due to selected pore size and column dimensions,
we were able to separate mAb monomer and aggregates
from interfering signals caused by DNA, host cell and
culture medium components. The high resolution of
these columns enabled quantification of mAb monomer
and aggregate content directly from cell culture samples.
In order to distinguish between the aggregates formed in
cell culture, mAb aggregates differing in size and morph-
ology were induced using different stress methods. The
different high molecular weight (HMW) species were
identified as dimers, tetramers, oligomers and large parti-
cles with hydrodynamic diameters greater than 100 nm.
Additionally, stability and traceability of the induced mAb
aggregates under conditions similar to the cell culture
environment were shown. The induced aggregates served
as standards for aggregate analysis in the culture super-
natant. Finally, we analyzed aggregate formation of a
mAb-producing CHO DG44 cell line to demonstrate that
monomer and aggregates were detectable and quantifiable
directly in the supernatant without a pre-purification step.
Methods
Monoclonal antibodies, cell line and media
Two aggregation-prone monoclonal antibodies (mAb1
and mAb2) were used as model proteins for this study.
The mAbs were produced in CHO DG44 cells [20,21].
The cells were cultivated in defined protein-free medium
(SFM4CHO, Thermo Scientific). A non-producing CHO
DG44 cell line was used as control, which was supple-
mented with hypoxanthine and thymidine (HT). The
antibodies were Protein A purified, filtered (0.2 μm) and
stored in 20 mmol L−1 acetate at pH 3.5 for further
studies. After stress induction the samples were filtered
(0.2 μm) prior to SE-HPLC analysis.Generation of different mAb aggregates
A pH-shift, high-salt concentration or freeze-thawing
(FT) were used to induce different types of mAb aggre-
gates. The antibodies were diluted to a final concentra-
tion of 1 mg mL−1 for the aggregation studies and
analyzed immediately after stress-induction.
In order to generate pH-dependent aggregation, the
mAbs were diluted in 100 mmol L−1 citric acid (2-hydro-
xypropane-1,2,3-tricarboxylic acid) and 200 mmol L−1
disodium hydrogen phosphate (Na2HPO4) with pH
values ranging from pH 3–8. For exposure to high salt
concentrations the mAbs were diluted to final sodium
chloride (NaCl) concentrations ranging from 0.1 to
1.5 mol L−1. For this purpose, a 5 mol L−1 NaCl stock
solution was prepared using ultrapure water (Millipore).
Moreover, both antibodies were subjected to multiple FT
cycles. One FT cycle included storage at −80°C for 15 min,
followed by thawing at 25°C for 15 min in a thermal mixer
(HLC Biotech).
SE-HPLC analysis
Analysis of soluble aggregates was performed using
an Agilent 1100 HPLC (Agilent Technologies) system
and an UltiMate 3000 (Thermo Scientific) system.
TSKgel G3000SWXL (Tosoh Bioscience), Yarra SEC-4000
(Phenomenex) and MAbPac SEC-1 (Thermo Scientific)
were used as SEC columns. The column properties are
listed in the Additional file 1: Table S1. The SEC separ-
ation was performed at ambient temperature isocratically
using a mobile phase consisting of phosphate-buffered
saline (PBS), which was adjusted to pH 7.2 and filtered
0.1 μm prior to use. Flow rates varied between 0.3, 0.5
and 0.8 mL min−1. The respective amounts of mAb
monomer, aggregates and fragments were quantified by
calculation of the peak areas detected by the ultraviolet
(UV) detectors. The UV signal of the Agilent 1100
system was displayed in mV, the signal of the Ultimate
3000 system in mAU. All samples were pre-filtered
using 0.2 μm syringe filters (Phenomenex).
Dynamic light scattering (DLS)
Formation of large aggregates was determined using a
Zetasizer 3000 HS instrument (Malvern Instruments) at
25°C. The average hydrodynamic diameter (Zave) of the
HMW species was measured in disposable semi-micro
UV cuvettes (Brand).
Molecular weight determination
The molecular weight of the aggregates was determined
using SEC in combination with multi-angle light scatter-
ing (MALS). SEC-MALS was performed using an Äkta
Explorer 100 instrument (GE Healthcare) equipped with
a Yarra SEC-4000 column (Phenomenex), an Optilab T-
Rex refractive index (RI) detector (Wyatt) and a DAWN
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analyzed at room temperature (RT) using 0.1 μm filtered
PBS (pH 7.0).
Stability of the induced aggregates
To investigate aggregate stability, mAb2 was stressed
using 500 mmol L−1 NaCl or three cycles of FT, respect-
ively, in order to induce dimer and oligomer formation
and measured after storage at RT for up to 72 h. To
investigate the traceability under cell culture conditions,
stressed antibody samples were spiked into SFM4CHO
medium or CHO DG44 host cell supernatant and
analyzed immediately afterwards.
Aggregate formation in mAb-producing CHO cell line
To investigate aggregate formation in cell culture, CHO
DG44 cells producing mAb2 were analyzed directly after
inoculation and after 144 h of cultivation, respectively. For
this purpose, cells were seeded at an initial concentration
of 4 × 105 mL−1 in 125 mL shake flasks (Corning) with a
working volume of 25 mL. Cultivation was performed in
SFM4CHO medium supplemented with 10 g L−1 glucose
and 4 mmol L−1 glutamine at 37°C, 140 rpm, 80% humid-
ity and 5% CO2. For analysis of mAb aggregate content
using SE-HPLC, cells were separated at 10.000 g for 5 min
and the supernatant was filtered (0.2 μm).
Determination of DNA and host cell proteins
To ensure the absence of DNA and HCPs in the SEC frac-
tions used for aggregate quantification, the corresponding
fractions of the CHO mAb2 supernatant were collected
(fraction volume: 98 μL) and analyzed. For DNA quantifi-
cation, the fractions were analyzed using a NanoDrop
1000 spectrophotometer (Thermo Scientific). For the de-
termination of HCP and culture medium components, the
SEC fractions were separated using sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) and pro-
tein bands were detected using silver staining. To receive
sufficient amounts for analysis the SEC fractions were
pooled and concentrated. Concentration was performed
using Vivaspin 500 with a 3 kDa molecular weight cut-off
(Sartorius Stedim Biotech). SDS-PAGE was performed at
160 V for 70 min at RT under reducing conditions with
an Amersham ECL Gel Box and a 4-20% Amersham ECL
Gel (GE Healthcare). Purified mAb2 and supernatant of
non-producing CHO cells served as controls. PageRuler
Prestained Protein Ladder (Thermo Scientific) was used
as size standard.
Results and discussion
SEC-based analysis of mAb aggregates in cell culture
supernatant
MAbs produced in mammalian cells are secreted into the
cell culture supernatant, where formation of aggregatescan be detected using SEC analysis after a Protein A cap-
ture step [4,15]. This approach is time-consuming, labori-
ous and can critically influence the aggregation status.
Direct analysis of cell culture samples containing mAb
using SEC is complicated, since components such as
DNA, lipids and HCPs can interfere with the analysis of
the product [10]. Accordingly, analysis of CHO mAb2 fer-
mentation supernatant samples using a common SEC col-
umn (TSKgel G3000SWXL) was insufficient and therefore
confirmed that separation of mAb monomer from
other supernatant signals disturbed aggregate detection
(Figure 1A). Since analysis of cell culture samples using
SEC appeared to be a problem of separation capacity,
columns promising higher separation efficiencies were
tested. Using a SEC column specifically designed for
mAb analysis (MAbPac SEC-1) showed that cell culture
medium components eluted later than purified mAb
monomer (Figure 1B). Serum-free media often contain
growth factors, lipoproteins and other factors as
growth-promoting supplements. It was confirmed that
none of the media components interfered with the ana-
lysis of the mAb2 monomer as these components
showed higher retention times. Furthermore, analysis
of the supernatant from the CHO DG44 culture using a
3 μm SEC column (Yarra SEC-4000) revealed that also
the cell culture components in the supernatant eluted
later than the mAb monomer (Figure 1C). These host
cell components, i.e. cellular proteins, DNA and other com-
ponents usually complicate the detection of target proteins
[22]. Our results indicated that cell culture and medium
impurities eluted later than the mAb monomer using
columns providing sufficiently high separation efficiency.
Therefore, both columns were tested for their applicability
for the analysis of mAb aggregates in cell culture samples.
Generation of different mAb aggregates
For aggregate detection during cultivation, one need to be
capable of measuring and characterizing all types of aggre-
gates potentially present in the culture broth. Therefore,
different types of mAb aggregates were generated by ap-
plying different stress conditions. Since pH changes and
increase of osmolality are both known phenomena occur-
ring in cell culture, pH-shift and high salt concentration
were used as induction methods. Furthermore, to generate
high amounts of soluble aggregates, FT was additionally
used as unnatural stress condition. To distinguish between
the different HMW species, the molecular weight was
determined using SEC-MALS. The various stress methods
induced different mAb aggregates, which were used as
standards for the analysis of cell culture supernatants.
pH-shift
As mentioned in the introduction, the pH-shift required
for Protein A chromatography favors the formation of
Figure 1 SEC analysis of mAb2 cell culture samples. CHO cell culture supernatant analyzed using a common SEC (TSKgel G3000SWXL)
column (A). Analysis of purified mAb2 compared to SFM4CHO medium using MAbPac SEC-1 (B) and CHO DG44 supernatant using Yarra
SEC-4000 (C).
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yields [17]. Thus, a pH-shift can also be used to induce
mAb aggregates. The different antibodies, mAb1 and
mAb2, were exposed to different pH values ranging from
pH 3–8, which resulted in the formation of small as well
as large aggregates (Table 1). With increasing pH a loss
of mAb2 monomer was observed accompanied by the
formation of mAb1 and mAb2 dimer. At pH 3 mAb1
consisted of only 1.8% dimer and mAb2 of 1.7% dimer,
whereas 3.4% and 6.3% dimer were visible at pH 8, re-
spectively. Additionally, a pH shift induced the gener-
ation of mAb2 oligomer and a smaller fragment.
Oligomer was elevated at pH 3, but less prominent for
other pH values. The correlation between pH increase
and dimer formation has already been previously de-
scribed [23]. Ishikawa et al. showed a pH-dependent
fragment formation of different antibodies [24]. The
antibody used in their study showed most aggregate for-
mation at neutral pH, which is consistent with our re-
sults. However, in their work the amount of lower
molecular weight species was highest at pH 4, whereas
mAb2 formed more fragments at higher pH values. Add-
itionally, DLS revealed a pH-induced formation of large
mAb aggregates. With an average diameter greater than
80 nm, the Zave of mAb1 at pH 5 and 6 was more than
2 times higher than at pH 3 (34.2 nm ±1.8 nm) and 4
(32.5 nm ±3.3 nm). MAb2 formed large aggregates at
pH 5 with a diameter greater than 100 nm, whereas at
other pH values the average diameter was smaller than
50 nm. Since both antibodies formed large aggregatesTable 1 Formation of mAb dimer, oligomer, fragment and lar
mAb1 m
Dimer (%) Oligomer (%) Zave (nm) D
pH
3 1.8 - 34.2 ± 1.8 1
4 1.9 - 32.5 ± 3.3 2
5 2.3 - 84.3 ± 15.0 2
6 2.6 - 85.7 ± 1.9 3
7 3.1 - 51.1 ± 5.3 4
8 3.4 - n. a. 6
NaCl
Control 0.6 - 33.7 ± 5.3 1
500 mM 1.3 - 23.8 ± 0.2 3
1 M 1.7 - 24.8 ± 0.6 4
1.5 M 2.0 - 24.2 ± 1.6 4
FT
Control 0.6 - 19.7 ± 1.1 1
1× 16.0 11.3 20.7 ± 1.8 1
2× 20.2 16.3 26.6 ± 1.9 1
3× 22.7 11.0 27.3 ± 2.8 2and mAb2 was also degraded to fragments, pH-shift was
not used for further stability studies and for the gener-
ation of aggregate standards.
NaCl
Increased salt concentration reduces the colloidal stabil-
ity by suppressing electrostatic repulsion, leading to ag-
gregation [25]. We used this mechanism to induce
aggregation of the two model proteins. The use of differ-
ent NaCl concentrations induced the formation of small
aggregates as well as large aggregates (Table 1). In
comparison to pH-shift induced aggregation, fewer ag-
gregates were formed using NaCl, but it is worth men-
tioning that NaCl-induction specifically formed one
smaller HMW species. Using SEC-MALS, the molecu-
lar weight of the NaCl-induced HMW species was
determined as a 300 kDa mAb2 dimer (Figure 2A). In
addition, the light scattering signal revealed the presence
of a large aggregate population, which was not visible
using UV detection. With increasing NaCl concentrations
mAb1 monomer content decreased and dimer increased
from 0.6% (w/o NaCl) to 2.0% (1.5 mol L−1 NaCl). Similar
to mAb1 also mAb2 monomer decreased with increasing
NaCl concentration, whereas the dimer content increased
more than fourfold from 1.1% (w/o NaCl) to 4.6%
(1.5 mol L−1 NaCl). In contrast to mAb2, mAb1 also
formed some degradation products. Our results correlate
with the results of Fesinmeyer et al., who reported that
even in milli-molar concentrations, salts promote mAb
aggregate formation [26]. They suggested anion binding asge aggregates using the different induction methods
Ab2
imer (%) Oligomer (%) Fragment (%) Zave (nm)
.7 1.8 - 39.6 ± 2.4
.1 0.9 - 49.5 ± 3.5
.0 0.9 3.5 144.9 ± 35.8
.5 0.6 5.7 47.9 ± 1.3
.0 0.5 4.5 45.7 ± 0.8
.3 0.6 6.3 n. a.
.1 - - 33.2 ± 0.2
.0 - - 41.8 ± 1.9
.2 - - 56.6 ± 8.8
.6 - - 78 ± 9.2
.4 - - 10.6 ± 1.1
7.1 3.6 - 14.4 ± 0.1
9.3 3.9 - 12.9 ± 0.5
1.0 6.6 - 12.1 ± 0.5
Figure 2 Molecular weight determination of mAb aggregate standards. MAb2 aggregate standards were induced using either NaCl (A) or FT
(B) and analyzed using SEC-MALS.
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formational stability and reduced valence. Analysis with
DLS revealed that mAb2 also formed large aggregates
(Table 1). NaCl-induction increased the aggregate size up
to an average diameter of around 75 nm (1.5 mol L−1
NaCl). However, mAb1 did not form large aggregates.
Our work showed that increasing ionic strength by
100 mmol L−1 NaCl is sufficient to induce mAb dimers,
and at concentrations higher than 500 mmol L−1 also to
induce larger mAb aggregates. Cation concentration in
the culture broth increases during the fermentation
process due to pH control [27]. Consequently, osmolality
in the bioreactor increases over time thus NaCl-induced
aggregates are likely to be present in the cell culture broth.
Since 500 mmol L−1 NaCl induced a significant amount of
small aggregates (3.0% dimer) without forming large
HMW species of mAb2, this concentration was used to
induce mAb2 dimers for stability studies and the gener-
ation of aggregate standards.
Freeze-thawing (FT)
Protein aggregation by FT is attributed to partial unfold-
ing caused by perturbing conditions like low temperature,
buffer crystallization, exposure to the ice-liquid interface,
adsorption to the container surface, increasing salt or pro-
tein concentration [28]. Using FT, both of our model pro-
teins showed the highest aggregation propensity, which
illustrated the impact of perturbation on protein stability
(Table 1). The aggregates formed by FT were identified as
dimer and tetramer (Figure 2B). Again, the light scattering
signal showed the presence of a large aggregate popula-
tion, which was already visible using NaCl-induction, but
not measurable using UV detection. Increasing the num-
ber of FT cycles resulted in a loss of mAb1 monomer with
a corresponding increase of mAb1 dimer (22.7%) and
tetramer (11.0%) after three cycles of FT. Similarly, mAb2
comprised around 21.0% dimer and 6.6% tetramer after
three cycles of FT. With more than 20% dimer formation,
FT induced three times higher aggregate levels than pH-shift to pH 8 (6.3% dimer) and more than four times
higher as the highest NaCl concentration (4.6% dimer).
Furthermore, FT led to the formation of a significant
amount of oligomers (11.0% mAb1, 6.6% mAb2), which
were not formed to that extent using the other stress
methods. FT also induced formation of large aggregates,
which were detectable using DLS. With increasing FT
cycle the hydrodynamic diameter of mAb1 aggregates in-
creased from 20 nm to above 25 nm, corresponding to the
monomer loss visible in the SEC chromatogram. Interest-
ingly, mAb1 showed the highest transformation rate after
three cycles of FT, whereas mAb2 formed most dimer,
oligomer and large aggregates after one FT cycle. Our re-
sults coincide with Hawe et al., who observed an increase
in Zave and the polydispersity index (PdI) caused by
FT-induced large and heterogeneous aggregates [29].
Furthermore, our results are also in good accordance
with other reports [30]. Since FT induced more aggre-
gates than the other stress methods, this technique was
chosen in addition to NaCl-induction for further stabil-
ity studies and the generation of aggregate standards.
Stability of the induced aggregates
In order to ensure stability of the aggregate standards,
mAb1 and mAb2 were stressed and analyzed after stor-
age at RT. To ensure traceability of the standards in
conditions similar to the cell culture environment, the
induced aggregates were further analyzed after spiking
into cell culture medium and the supernatant of non-
producing CHO DG44 cells, respectively.
To evaluate stability of NaCl-induced aggregates, mAb1
and mAb2 aggregates were induced using 500 mmol L−1
NaCl and analyzed after storage at RT for up to 72 h
(Figure 3A-D). MAb1 dimer content increased already
after 2 h from 1.3% to 3.3% (Figure 3B) and mAb2 dimer
increased within 72 h from 6.5% to 10.2% (Figure 3D),
revealing that the aggregation reaction was not finished
within this time period. These observations are in good
accordance with other reports [26,31,32]. Stability analysis
Figure 3 (See legend on next page.)
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Figure 3 Stability and traceability of mAb aggregate standards. The stability of NaCl-induced mAb1 (A + B) and mAb2 (C + D) aggregates
was investigated. B is an enlargement of A, D is an enlargement of C. (E) Stability of FT-induced mAb1 using MAbPac SEC-1. (F) Stability of
FT-induced mAb2 aggregates using Yarra SEC-4000. (G) Traceability of NaCl-induced mAb2 aggregates using MAbPac SEC-1. (H) Traceability of
FT-induced mAb2 aggregates using Yarra SEC-4000 under cell culture conditions.
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formed were readily reversible (Figure 3E + F). MAb1
tetramer increased from 11% to 26% after 2 h storage
at RT (Figure 3E). FT-induced aggregates of mAb2
seemed to be reversible. Increasing storage time at
room temperature resulted in mAb2 monomer recov-
ery with a corresponding decrease in dimer and oligo-
mers (Figure 3F). After 1 h storage at RT, FT-induced
mAb2 dimer decreased from 14% to 4% and the tetra-
mer from 2.5% to 0.3%, whereas mAb2 monomer
increased from 82.6% to 95.7%. This shift in aggregate
distribution was also observed by Philo, who reported
that incubation of Protein X at 29°C after FT led to a
drop in dimer and larger aggregate content, with a
corresponding increase in monomer [33]. Since Philo
used Protein X, our results are the first report, to the
best of our knowledge, which showed the reversibility
of FT-induced aggregates for mAbs. Since the aggre-
gates induced by NaCl and FT were unstable, all ag-
gregate standards were prepared freshly for further
experiments.
To study traceability under cell culture conditions,
NaCl-induced mAb2 was spiked into SFM4CHO cell
culture medium (Figure 3G). Monomer as well as mAb2
aggregates were still detectable in this matrix. Given that
the medium components of the serum-free cell culture
medium eluted later than mAb2 monomer, quantifica-
tion of monomer and aggregate content was feasible.
With 3% dimer and 97% monomer the values were con-
sistent to NaCl-induced aggregate formation of mAb2
(Table 1). Furthermore, we showed that the dimers and
tetramers induced by FT were also detectable and quan-
tifiable in the supernatant of non-producing CHO DG44
cells (Figure 3H). HCPs and culture medium compo-
nents eluted later than mAb2 monomer and aggregates
without influencing aggregate quantification. In total
22% dimer, 6% oligomer and 72% remaining monomer
was determined for mAb2, which correlated well to the
results obtained from freeze-thawed mAb2 (Table 1).
The spiking experiments demonstrated that the aggre-
gates induced by the selected stress methods were stable
during the experiment and still detectable under condi-
tions expected in cell culture. Since the high resolution
facilitated by the 3 μm SEC column enabled sufficient
efficiency to separate mAb monomer and aggregates
from CHO DG44 cell culture components, aggregate
formation in the culture of a mAb-producing CHO cell
line was investigated using this column.Aggregate formation in a mAb-producing CHO cell line
To demonstrate the feasibility of the method, the cell-
free supernatant derived from a culture of a mAb2-
producing CHO cell line was analyzed for aggregate
formation. In order to ensure typical growth, culture
parameters such as viability and viable cell concentra-
tion as well as substrate, metabolite and product concen-
trations were measured during cultivation. Cell culture
samples were taken every 24 h, and aggregation analysis
was performed directly after inoculation and after 144 h of
cultivation.
The cultivation showed typical growth, substrate and
metabolite concentrations for mAb production (Additional
file 2: Figure S1). Directly after inoculation neither mono-
mer nor mAb aggregates were detected (Figure 4A + B).
Chromatograms of the SE-HPLC analysis obtained from
the supernatant of the three shake flasks showed identical
results (Figure 4B). Retention times of the signals obtained
immediately after the start of cultivation (14–16 min)
corresponded to the elution times obtained in the ana-
lysis of the cell-free supernatant from a culture of a
non-producing CHO DG44 host cell line (Figure 3H),
indicating that the signals were caused by host cell im-
purities and medium components such as DNA, lipids,
HCPs, secreted cellular metabolites and excess nutri-
ents [10,34]. To ensure that these cell culture contami-
nants do not interfere with quantification of the mAb2
monomer and aggregates in the CHO supernatant, the
corresponding chromatography fractions were collected
and analyzed for DNA (Figure 4C) and HCPs (Figure 4D).
DNA analysis of the collected SE-HPLC fractions revealed
that the CHO mAb2 supernatant contained a significant
amount of DNA (up to 15 ng μL−1). The finally formu-
lated recombinant mAb product has to contain less than
10 ng/dose DNA [35]. Therefore the impurities have to be
removed from the cell culture supernatant after harvest
using several DSP operations [22]. However, DNA was
detected only in the fractions containing host cell and
culture medium components and not observed in the SEC
fractions used for mAb aggregate quantification. In order
to determine the amount of HCPs, the corresponding
SEC fractions were pooled, concentrated and separated
using reducing SDS-PAGE with subsequent silver staining
(Figure 4D). The supernatant of the non-producing CHO
cells (DG44) and the supernatant of the mAb2-producing
CHO cells (CHO mAb2) both showed a huge amount of
signals, indicating presence of HCPs in the supernatant.
The strongest bands in the mAb2-producing CHO
Figure 4 Analysis of mAb aggregate formation, DNA content, host cell and medium components in the supernatant of a mAb2-producing
CHO cell line. Supernatant was analyzed for mAb aggregate formation directly after inoculation and after 144 h cultivation (A + B). Amount of mAb2
monomer, dimer and oligomers was obtained from biological triplicates ± standard deviation. B is an enlargement of A. DNA content of collected SEC
fractions was analyzed using NanoDrop 1000 spectrophotometer (C). For determination of HCPs and culture medium components, SEC fractions were
pooled, concentrated and analyzed using SDS-PAGE under reducing conditions with subsequent silver staining (D).
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50 kDa) and the light chain (around 25 kDa) of reduced
mAb2, also visible in the purified mAb2 control (Ctr).
Analysis of the collected SEC fractions revealed that the
mAb2 monomer and aggregate fraction contained mainly
heavy and light chain, indicating that nearly no HCPs were
present. The monomer and aggregate fraction showed a
signal at 150 kDa caused by unreduced mAb2 as well as
bands between heavy and light chain, which were also
visible in the control, whereas the fractions collected from
host cell and culture medium components showed add-
itional signals. It is known that mammalian cells secrete
HCPs together with the product [36]. Nevertheless, the
mAb2 monomer and aggregate fractions collected from
the SE-HPLC analysis contained no detectable amounts of
DNA and were nearly free of HCP enabling mAb aggre-
gate quantification directly in the supernatant of CHOcells using the SEC columns tested in this work. However,
the results also revealed the presence of a large amount of
DNA and cell culture components in the supernatant of
CHO cell culture and emphasize the importance of the
use of appropriate SEC columns for aggregate analysis.
These interfering components may be the reason why
analysis of protein aggregation during cell culture was
mainly performed after a Protein A capture step in other
experiments [11-13,37]. Franco et al. used an analytical
gel filtration column with 13 μm bead size, which had a
lower resolution than the 3 μm SEC column used in our
work. Ho et al. and Jing et al. performed their experi-
ments with the same column type, which showed insuffi-
cient separation of mAb monomer from other cell culture
signals in our experiments (Figure 1A). This could explain
why in those experiments a pre-purification step was
necessary to detect aggregates in cell culture samples.
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pool is dependent on the host organism, the protein of
interest as well as culture and harvest conditions [38]. It is
conceivable that the production cell line as well as the
non-producing CHO DG44 cell line used in this work did
not secrete HCPs, which interfere with mAb monomer
and aggregates enabling a smooth quantification. Using
our method, mAb monomer and aggregates were detect-
able directly in the supernatant of CHO mAb producer
cells after 144 h of cultivation without interfering with
host cell impurities (Figure 4A + B). Quantification of
aggregate formation revealed that a huge amount of mAb
consisted of aggregates. Comparison of the cell culture
samples to retention times of the aggregated mAb stan-
dards indicated that the aggregates comprised of dimer
and a huge amount of larger oligomers. Figure 4B shows
the mean values of monomer, dimer and larger aggregates
resulting from all shake flasks. With only 23% ±0.4%
remaining monomer, the supernatant after 144 h com-
prised of 10% ±0.3% dimer and 67% ±0.7% larger oligo-
mers (Figure 4B). This is the first report demonstrating
such a high amount of aggregates during CHO cell
culture. Franco et al. found about 10% aggregates in all
harvest batches of hybridoma cells secreting a monoclonal
anti-PSA antibody [13]. Other work using IgG-producing
CHO cells reported aggregation rates from 20% up to 30%
[7,39]. Ho et al. obtained an aggregate and fragment
content of more than 50% by decreasing the light chain to
heavy chain (LC:HC) ratio [37]. As mentioned before,
most of these approaches measured mAb aggregate
formation after a Protein A purification step. This step
included loading of the mAbs to the Protein A column
under neutral conditions, elution under acidic conditions
and neutralization before applying SEC analysis [10,40].
During elution and neutralization the mAbs undergo crit-
ical pH values (pH 5 and 6), which induced very large
aggregates in our pH-shift experiments (Table 1). With a
diameter above 100 nm at pH 5, the mAb2 aggregates
induced by pH-shift were by far larger than using the
highest NaCl concentration and three cycles of FT. These
large aggregates may be filtered during sample preparation
or get stuck in the column matrix and could therefore be
underrepresented in the subsequent SEC analysis. This
would explain the varying amount of aggregates detected
in DSP and emphasizes the importance of a more direct
method for upstream aggregate analysis. Directly analyz-
ing mAb cell culture samples using high resolution SEC
columns does not include shifts to critical pH values.
Although the mAbs used in this work were aggregation-
prone, our results indicate how much protein may be lost
due to formation of HMW species during cell culture. It
can be assumed that the HMW species were product-
related, since the supernatant of non-producing CHO cells
showed no comparable signals (Figure 3H) and the SECfractions used for mAb aggregate quantification contained
neither DNA nor significant amounts of HCP and culture
medium components (Figure 4C + D). Furthermore, the
large aggregates detected in the supernatant of the
mAb2-producing CHO cell line were also visible in the
Rayleigh ratio after NaCl- and FT-induction of purified
mAb2 (Figure 2). Our results demonstrate that SE-
HPLC analysis using a high-resolution column in com-
bination with suitable aggregate standards can be a
valuable tool to determine aggregate formation in cell
culture, as the method allows quantification of mAb
aggregate content within 20 min directly in the cell
culture supernatant without falsifying the results by
labor-intensive pre-purification of the samples.
Conclusions
In this study, we have investigated SEC-based quantifica-
tion of mAb aggregates directly in the supernatant of
CHO cell cultures without a pre-purification step. High-
resolution SEC columns enabled separation of mAb
monomer and aggregates from interfering cell culture
components such as DNA, host cell and culture medium
contaminants. In order to distinguish between different
HMW species formed in cell culture, mAb dimers, tetra-
mers, oligomers and large aggregates with diameter
above 100 nm were induced using different stress tech-
niques to be used as aggregate standards. The induced
aggregates were still detectable under conditions similar
to the cell culture environment. Finally, we demon-
strated that the method is applicable to quantify aggre-
gates in the supernatant of a mAb2-producing CHO cell
line. The results indicated that over 75% percent of mAb
was aggregated proving that aggregate formation may
already have its origin in the cell culture and is not only
a problem in DSP.
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Abbreviations
CHO: Chinese Hamster Ovary; DLS: Dynamic light scattering; DSP: Downstream
processing; FT: Freeze-thawing; HCP: Host cell protein; HMW: High molecular
weight; HPLC: High pressure liquid chromatography; mAbs: Monoclonal
antibodies; MALS: Multi angle light scattering; PBS: Phosphate-buffered saline;
RI: Refractive index; RT: Room temperature; SEC: Size exclusion chromatography;
USP: Upstream processing; UV: Ultraviolet; Zave: Zeta average.
Competing interests
The authors declare that they have no competing interests.
Paul et al. BMC Biotechnology 2014, 14:99 Page 11 of 11
http://www.biomedcentral.com/1472-6750/14/99Authors’ contributions
AP performed all the experiments and drafted the manuscript. KS has been
involved in drafting the manuscript and revising it critically for important
intellectual content. FH conceived of the study, revised it critically and
participated in its design and coordination and helped to draft the manuscript.
All authors read and approved the final manuscript.Acknowledgements
This research was supported by the German Federal Ministry of Education and
Research (Grant No. 0315342A). The authors are grateful to Boehringer
Ingelheim Pharma GmbH & Co for providing the mAb1-producing CHO cell line
and Rentschler Biotechnologie GmbH for providing the mAb2-producing CHO
cell line.
Received: 6 June 2014 Accepted: 14 November 2014References
1. Sliwkowski MX, Mellman I: Antibody therapeutics in cancer. Science 2013,
341:1192–1198.
2. Holliger P, Hudson PJ: Engineered antibody fragments and the rise of
single domains. Nat Biotechnol 2005, 23:1126–1136.
3. Leavy O: Therapeutic antibodies: past, present and future. Nat Rev
Immunol 2010, 10:297.
4. Wurm FM: Production of recombinant protein therapeutics in cultivated
mammalian cells. Nat Biotechnol 2004, 22:1393–1398.
5. Vázquez-Rey M, Lang DA: Aggregates in monoclonal antibody
manufacturing processes. Biotechnol Bioeng 2011, 108:1494–1508.
6. Dengl S, Wehmer M, Hesse F, Lipsmeier F, Popp O, Lang K: Aggregation
and chemical modification of monoclonal antibodies under upstream
processing conditions. Pharm Res 2013, 30:1380–1399.
7. Kramarczyk JF, Kelley BD, Coffman JL: High-throughput screening of
chromatographic separations: II. Hydrophobic interaction. Biotechnol
Bioeng 2008, 100:707–720.
8. Perchiacca JM, Tessier PM: Engineering aggregation-resistant antibodies.
Annu Rev Chem Biomol Eng 2012, 3:263–286.
9. Paul R, Graff-Meyer A, Stahlberg H, Lauer ME, Rufer AC, Beck H, Briguet A,
Schnaible V, Buckel T, Boeckle S: Structure and function of purified
monoclonal antibody dimers induced by different stress conditions.
Pharm Res 2012, 29:2047–2059.
10. Pan H, Chen K, Pulisic M, Apostol I, Huang G: Quantitation of soluble
aggregates in recombinant monoclonal antibody cell culture by pH-
gradient protein A chromatography. Anal Biochem 2009, 388:273–278.
11. Jing Y, Borys M, Nayak S, Egan S, Qian Y, Pan S-H, Li ZJ: Identification of cell
culture conditions to control protein aggregation of IgG fusion proteins
expressed in Chinese hamster ovary cells. Process Biochem 2012, 47:69–75.
12. Yang WC, Lu J, Nguyen NB, Zhang A, Healy NV, Kshirsagar R, Ryll T, Huang
Y-M: Addition of Valproic Acid to CHO Cell Fed-Batch Cultures Improves
Monoclonal Antibody Titers. Mol Biotechnol 2014, 56(5):421–428.
13. Franco R, Daniela G, Fabrizio M, Ilaria G, Detlev H: Influence of osmolarity
and pH increase to achieve a reduction of monoclonal antibodies
aggregates in a production process. Cytotechnology 1999, 29:11–25.
14. Rea JC, Moreno GT, Vampola L, Lou Y, van Haan B, Tremintin G, Simmons L,
Nava A, Wang YJ, Farnan D: Capillary size exclusion chromatography with
picogram sensitivity for analysis of monoclonal antibodies purified from
harvested cell culture fluid. J Chromatogr A 2012, 1219:140–146.
15. Cromwell MEM, Hilario E, Jacobson F: Protein aggregation and
bioprocessing. AAPS J 2006, 8:E572–E579.
16. Chi EY, Krishnan S, Randolph TW, Carpenter JF: Physical stability of
proteins in aqueous solution: mechanism and driving forces in
nonnative protein aggregation. Pharm Res 2003, 20:1325–1336.
17. Arosio P, Rima S, Morbidelli M: Aggregation mechanism of an IgG2 and
two IgG1 monoclonal antibodies at low pH: from oligomers to larger
aggregates. Pharm Res 2013, 30:641–654.
18. Phillips J, Drumm A, Harrison P, Bird P, Bhamra K, Berrie E, Hale G:
Manufacture and quality control of CAMPATH-1 antibodies for clinical
trials. Cytotherapy 2001, 3:233–242.
19. Mahler H-C, Jiskoot W: Analysis of Aggregates and Particles in Protein
Pharmaceuticals. Hoboken, New Jersey: John Wiley & Sons; 2012.20. Urlaub G, Chasin LA: Isolation of Chinese hamster cell mutants deficient
in dihydrofolate reductase activity. Proc Natl Acad Sci U S A 1980,
77:4216–4220.
21. Urlaub G, Emmanuel K, Carothers AM, Chasin LA: Deletion of the diploid
dihydrofolate reductase locus from cultured mammalian cells. Cell 1983,
33(June):405–412.
22. Guiochon G, Beaver LA: Separation science is the key to successful
biopharmaceuticals. J Chromatogr A 2011, 1218:8836–8858.
23. Ahrer K, Buchacher A, Iberer G, Jungbauer A: Detection of aggregate
formation during production of human immunoglobulin G by means of
light scattering. J Chromatogr A 2004, 1043:41–46.
24. Ishikawa T, Ito T, Endo R, Nakagawa K, Sawa E, Wakamatsu K: Influence of
pH on heat-induced aggregation and degradation of therapeutic
monoclonal antibodies. Biol Pharm Bull 2010, 33:1413–1417.
25. Saito S, Hasegawa J, Kobayashi N, Tomitsuka T, Uchiyama S, Fukui K: Effects
of ionic strength and sugars on the aggregation propensity of
monoclonal antibodies: influence of colloidal and conformational
stabilities. Pharm Res 2013, 30:1263–1280.
26. Fesinmeyer RM, Hogan S, Saluja A, Brych SR, Kras E, Narhi LO, Brems DN,
Gokarn YR: Effect of ions on agitation- and temperature-induced
aggregation reactions of antibodies. Pharm Res 2009, 26:903–913.
27. Schmelzer AE, DeZengotita VM, Miller WM: Considerations for osmolality
measurement under elevated pCO(2): comparison of vapor pressure and
freezing point osmometry. Biotechnol Bioeng 2000, 67:189–196.
28. Kueltzo LA, Wang WEI, Randolph TW, Carpenter JF: Effects of Solution
Conditions, Processing Parameters, and Container Materials on
Aggregation of a Monoclonal Antibody during Freeze-Thawing. J Pharm
Sci 2008, 97:1801–1812.
29. Hawe A, Kasper JC, Friess W, Jiskoot W: Structural properties of
monoclonal antibody aggregates induced by freeze-thawing and ther-
mal stress. Eur J Pharm Sci 2009, 38:79–87.
30. Printz M, Friess W: Simultaneous Detection and Analysis of Protein
Aggregation and Protein Unfolding by Size Exclusion Chromatography
with Post Column Addition of the Fluorescent Dye BisANS. J Chromatogr
A 2012, 101:826–837.
31. Arosio P: On the role of salt type and concentration on the stability
behavior of a monoclonal antibody solution. Biophys Chem 2012, 16:19–27.
32. Majumdar R, Manikwar P, Hickey JM, Samra HS, Sathish HA, Bishop SM,
Middaugh CR, Volkin DB, Weis DD: Effects of Salts from the Hofmeister
Series on the Conformational Stability, Aggregation Propensity, and
Local Flexibility of an IgG1 Monoclonal Antibody. Biochemistry 2013,
52:3376–3389.
33. Philo JS: Is any measurement method optimal for all aggregate sizes and
types? AAPS J 2006, 8:E564–E571.
34. Goh L-T, Yap MGS: Determination of interferon-gamma in Chinese
hamster ovary cell culture supernatant by coupled-column liquid
chromatography. J Sep Sci 2005, 28:2104–2110.
35. Chon JH, Zarbis-Papastoitsis G: Advances in the production and down-
stream processing of antibodies. N Biotechnol 2011, 28:458–463.
36. Hogwood CEM, Tait AS, Koloteva-levine N, Bracewell DG, Smales CM: The
Dynamics of the CHO Host Cell Protein Profile During Clarification and
Protein A Capture in a Platform Antibody Purification Process. Biotechnol
Bioeng 2013, 110:240–251.
37. Ho SCL, Koh EYC, van Beers M, Mueller M, Wan C, Teo G, Song Z, Tong YW,
Bardor M, Yang Y: Control of IgG LC:HC ratio in stably transfected CHO
cells and study of the impact on expression, aggregation, glycosylation
and conformational stability. J Biotechnol 2013, 165:157–166.
38. Jin M, Szapiel N, Zhang J, Hickey J, Ghose S: Profiling of host cell proteins by
two-dimensional difference gel electrophoresis (2D-DIGE): Implications for
downstream process development. Biotechnol Bioeng 2010, 105:306–316.
39. Gomez N, Subramanian J, Ouyang J, Nguyen MDH, Hutchinson M, Sharma
VK, Lin AA, Yuk IH: Culture temperature modulates aggregation of
recombinant antibody in CHO cells. Biotechnol Bioeng 2012, 109:125–136.
40. Koguma I, Yamashita S, Sato S, Okuyama K, Katakura Y: Novel purification
method of human immunoglobulin by using a thermo-responsive
protein A. J Chromatogr A 2013, 1305:149–153.
doi:10.1186/s12896-014-0099-3
Cite this article as: Paul et al.: Direct analysis of mAb aggregates in
mammalian cell culture supernatant. BMC Biotechnology 2014 14:99.
